September 2016
Volume 57, Issue 12
Open Access
ARVO Annual Meeting Abstract  |   September 2016
AAV-mediated MANF (mesencephalic astrocyte-derived neurotrophic factor) expression protects retinal ganglion cells in a retinal ischemia/reperfusion mouse model
Author Affiliations & Notes
  • Yanming Huang
    Bascom Palmer Eye Institute, University of Miami Miller School of Medicine, Miami, Florida, United States
    Xiamen Eye Centre, Xiamen University, Xiamen, Fujian, China
  • Zhenya Gao
    Bascom Palmer Eye Institute, University of Miami Miller School of Medicine, Miami, Florida, United States
    Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangzhou, China
  • Galina Dvoriantchikova
    Bascom Palmer Eye Institute, University of Miami Miller School of Medicine, Miami, Florida, United States
  • Dmitry V Ivanov
    Bascom Palmer Eye Institute, University of Miami Miller School of Medicine, Miami, Florida, United States
  • Yuan Kang
    Bascom Palmer Eye Institute, University of Miami Miller School of Medicine, Miami, Florida, United States
  • John Gerard Flannery
    Helen Wills Neuroscience Institute, University of California, Berkeley, California, United States
  • Rong Wen
    Bascom Palmer Eye Institute, University of Miami Miller School of Medicine, Miami, Florida, United States
  • Yiwen Li
    Bascom Palmer Eye Institute, University of Miami Miller School of Medicine, Miami, Florida, United States
  • Footnotes
    Commercial Relationships   Yanming Huang, None; Zhenya Gao, None; Galina Dvoriantchikova, None; Dmitry Ivanov, None; Yuan Kang, None; John Flannery, None; Rong Wen, None; Yiwen Li, None
  • Footnotes
    Support  Supported by NIH grants R01EY023666, R01EY022348, P30-EY014801, Adrienne Arsht Hope for Vision fund, and an unrestricted grant from Research to Prevent Blindness, Inc.
Investigative Ophthalmology & Visual Science September 2016, Vol.57, 4411. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to Subscribers Only
      Sign In or Create an Account ×
    • Get Citation

      Yanming Huang, Zhenya Gao, Galina Dvoriantchikova, Dmitry V Ivanov, Yuan Kang, John Gerard Flannery, Rong Wen, Yiwen Li; AAV-mediated MANF (mesencephalic astrocyte-derived neurotrophic factor) expression protects retinal ganglion cells in a retinal ischemia/reperfusion mouse model. Invest. Ophthalmol. Vis. Sci. 2016;57(12):4411.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Mesencephalic astrocyte-derived neurotrophic factor (MANF) is a member of a novel evolutionarily conserved protein family with neurotrophic capabilities. Previously we reported that recombinant human MANF protects photoreceptors in a retinal degeneration rat model. The present work investigates potential neuroprotective effects of MANF on retinal ganglion cells (RGC) using a mouse retinal ischemia–reperfusion (IR) model.

Methods : A viral vector AAV-MANF was used to deliver the MANF gene to retinal cells. The expression of MANF was driven by a CMV promoter. A control viral vector, AAV-GFP, was constructed by replacing the ORF of MANF with the ORF of GFP. Adult C57B/6J mice (3 months old) were used in all experiments. Animals were divided into 3 groups: IR only (n=5), IR+AAV-GFP (n=3), and IR+AAV-MANF (n=5). Three microliters of AAV-GFP (2x1013 vg/ml) or AAV-MANF (2x1013 vg/ml) were injected intravitreally into each eye 3 weeks prior to IR. The expression levels of MANF were assessed by Western blot analysis. Ischemia was achieved by increasing the intraocular pressure (IOP) to 120 mmHg for 45 min in the left eye. A 33-gauge needle connected to a reservoir of saline was inserted into the anterior chamber to get desired IOP by rasising the reservoir. The right eye was untreated as a control. Retinas were harvested 7 days after IR, stained with NeuN, and flat-mounted. NeuN positive cells in the retinas from both eyes were counted, and cell survival rate in the IR retinas was calculated as a percentile of the mean cell density of the control fellow eye.

Results : Seven days after IR, the remaining of RGCs in the control ischemic retinas without injection was 25±1%, indicating about 75% cell loss. A similar survival rate (21±3%) was found in retinas injected with AAV-GFP. In AAV-MANF treated retinas, however, the survival rate was 78±8%, significantly higher than the two control groups (P<0.001 compared with each control group). Analysis also showed the levels of MANF protein in the retina and vitreous in the AAF-MANF treated eyes were significantly higher than those in the two control groups.

Conclusions : Our results demonstrated that AAV-mediated MANF expression significantly protects against RGC loss. MANF thus could be considered as a clinical neuroprotective agent for retinal degenerative disorders.

This is an abstract that was submitted for the 2016 ARVO Annual Meeting, held in Seattle, Wash., May 1-5, 2016.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×